FORM 8.3 - STERIS CORPORATION

LONDON--()--

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)   Full name of discloser:   Barclays PLC.
     
(b) Owner or controller of interest and short
  positions disclosed, if different from 1(a):  
(c) Name of offeror/offeree in relation to whose STERIS CORPORATION
  relevant securities this form relates:  
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
  offeror/offeree:  
(e) Date position held/dealing undertaken: 06 October 2015
(f) In addition to the company in 1(c) above, is the discloser making YES:
  disclosures in respect of any other party to the offer? SYNERGY HEALTH PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:       ORD            
Interests Short Positions
    Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 2,899 0.00% 287,001 0.48%
           
(2) Cash-settled derivatives:
284,112 0.47% 0 0.00%
           
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
           
 
TOTAL: 287,011 0.48% 287,001 0.48%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant   Purchase/sale   Number of   Price per unit
security   securities  
ORD Purchase 11 65.7700 USD
ORD Purchase 24 65.4500 USD
ORD Purchase 24 65.2900 USD
ORD Purchase 51 65.1700 USD
ORD Purchase 86 66.1900 USD
ORD Purchase 86 65.4337 USD
ORD Purchase 89 65.7800 USD
ORD Purchase 100 64.9500 USD
ORD Purchase 100 65.9400 USD
ORD Purchase 100 65.8900 USD
ORD Purchase 150 65.8908 USD
ORD Purchase 300 65.4664 USD
ORD Purchase 300 65.1800 USD
ORD Purchase 349 65.3133 USD
ORD Purchase 400 65.3175 USD
ORD Purchase 500 65.2298 USD
ORD Purchase 500 65.7840 USD
ORD Purchase 533 65.3114 USD
ORD Purchase 800 65.3275 USD
ORD Purchase 880 65.1900 USD
ORD Purchase 2,600 65.3537 USD
ORD Purchase 2,671 65.2609 USD
ORD Purchase 2,800 65.4491 USD
ORD Purchase 2,867 66.0138 USD
ORD Purchase 3,100 65.3285 USD
ORD Purchase 3,600 65.4449 USD
ORD Purchase 14,959 65.2205 USD
ORD Sale 24 65.4500 USD
ORD Sale 86 65.4338 USD
ORD Sale 86 65.4337 USD
ORD Sale 100 65.1901 USD
ORD Sale 100 65.9900 USD
ORD Sale 200 65.1550 USD
ORD Sale 200 65.2150 USD
ORD Sale 200 64.9000 USD
ORD Sale 211 65.1600 USD
ORD Sale 250 65.9104 USD
ORD Sale 271 65.1800 USD
ORD Sale 300 64.8700 USD
ORD Sale 300 65.8173 USD
ORD Sale 300 64.8802 USD
ORD Sale 300 65.3433 USD
ORD Sale 348 65.6009 USD
ORD Sale 400 65.5275 USD
ORD Sale 500 65.5780 USD
ORD Sale 500 65.2940 USD
ORD Sale 600 65.6300 USD
ORD Sale 700 65.4154 USD
ORD Sale 780 65.1900 USD
ORD Sale 800 65.7225 USD
ORD Sale 1,124 65.4914 USD
ORD Sale 1,400 65.6038 USD
ORD Sale 1,900 65.1878 USD
ORD Sale 2,900 65.4520 USD
ORD Sale 4,250 65.1677 USD
ORD Sale 4,500 65.3179 USD
ORD Sale 6,650 65.1274 USD
ORD Sale 7,700 65.5944 USD

(b) Cash-settled derivative transactions

Class of relevant security   Product description

e.g. CFD

  Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

  Number of reference securities   Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security   Product description e.g. call option   Writing, purchasing, selling, varying etc.   Number of securities to which option relates   Exercise price per unit   Type

e.g. American, European etc.

  Expiry date   Option money paid/ received per unit

(ii) Exercise

Class of relevant security   Product description

e.g. call option

  Exercising/ exercised against   Number of securities   Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security   Nature of dealing

e.g. subscription, conversion

  Details   Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?   NO
Date of disclosure: 7 Oct 2015
Contact name: Jay Supaya
Telephone number: 020 7773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Short Name: BARCLAYS PLC
Category Code: RET
Sequence Number: 488450
Time of Receipt (offset from UTC): 20151007T142336+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC